[Contaminated heparins]

Area of Science:

• Pharmaceutical Science
• Chemical Analysis
• Public Health

Context:

• In January 2008, severe allergic reactions led to heparin recalls in the US.
• Similar side effects were noted in Germany, but not France, despite using heparin derived from potentially contaminated sources.
• Over 80 deaths in the US were linked to tainted injectable heparin.

Purpose:

• To investigate the cause of severe adverse events linked to heparin products.
• To identify the contaminant responsible for heparin-induced allergic reactions.
• To assess the implications for global heparin supply chain integrity and quality control.

Summary:

• Analyses revealed heparin batches contaminated with high levels of chondroitin sulfate (5-20%), a synthetic substitute.
• The contaminated heparin originated from Chinese chemical industries, which supply 50% of the world's heparin.
• This contamination represents a worldwide problem affecting the heparin supply chain.

Impact:

• The incident raises serious questions about the effectiveness of existing quality assurance and analytical controls in the pharmaceutical industry.
• There is an urgent need to enforce strict adherence to the pharmaceutical supply chain to prevent future quality issues.
• Ensuring the integrity of the global heparin supply is crucial for patient safety and public health.